Thermo Fisher Scientific Launches TurboTox GC/MS Productivity Solution for Drugs Abuse Testing

The US Substance Abuse and Mental Health Services Administration (SAMHSA) workplace drug testing program currently requires that GC/MS methods be used for confirmation of five drug classes. The methods included in the TurboTox GC/MS Productivity Solution have been fully validated in urine matrix for linearity, precision and specificity to ensure full compliance with these accepted practices.

The TurboTox GC/MS Productivity Solution is the first validated, total solution to be introduced to the market to include both standard operating procedures and consumables, extending from sample preparation through to sample analysis, resulting in utmost analytical confidence. ToxLab 2.0 software offers unparalleled intelligent sequencing, for optimal productivity and operational efficiency. ToxLab continuously monitors batches and modifies the batch as needed in real time. Users establish the level of intelligence required and ToxLab performs appropriate actions. Whether it is preventing carryover, re-injecting for ion ratio failures, or checking peak symmetry, ToxLab automates time-consuming processes and increases efficiency in the lab.

The TurboTox Productivity Solution allows users to enjoy the benefits of the DSQ II GC/MS instrument, including its high sensitivity and high upper limit of linearity, and ToxLab 2.0 software which reduces the need for costly retests when specimens quantitate outside of the instrument’s linear range.